Skip to main navigation Skip to search Skip to main content

Phase II Trial of Weekly Bortezomib in Combination With Rituximab in Relapsed or Relapsed and Refractory Waldenstrom Macroglobulinemia

  • Irene M. Ghobrial
  • , Fangxin Hong
  • , Swaminathan Padmanabhan
  • , Ashraf Badros
  • , Meghan Rourke
  • , Renee Leduc
  • , Stacey Chuma
  • , Janet Kunsman
  • , Diane Warren
  • , Brianna Harris
  • , Amy Sam
  • , Kenneth C. Anderson
  • , Paul G. Richardson
  • , Steven P. Treon
  • , Edie Weller
  • , Jeffrey Matous
  • Harvard University
  • Roswell Park Cancer Institute
  • University of Maryland, Baltimore
  • Rocky Mountain Cancer Center, Denver, CO, USA

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalBlood
Volume114
Issue number22
DOIs
StatePublished - Nov 20 2009
Externally publishedYes

Disciplines

  • Medicine and Health Sciences
  • Gastroenterology
  • Internal Medicine

Cite this